<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang H</submitter><funding>NCCIH NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>378-88, 388.e1-4</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3129489</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>141(1)</volume><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>Cholestasis contributes to hepatocellular injury and promotes liver carcinogenesis. We created a mouse model of chronic cholestasis to study its effects on progression of cholangiocarcinoma and the oncogenes involved.&lt;h4>Methods&lt;/h4>To induce chronic cholestasis, Balb/c mice were given 2 weekly intraperitoneal injections of diethylnitrosamine (DEN); 2 weeks later, some mice also received left and median bile duct ligation (LMBDL) and, then 1 week later, were fed DEN, in corn oil, weekly by oral gavage (DLD). Liver samples were analyzed by immunohistochemical and biochemical assays; expression of Mnt and c-Myc was reduced by injection of small inhibitor RNAs.&lt;h4>Results&lt;/h4>Chronic cholestasis was induced by DLD and accelerated progression of cholangiocarcinoma, co</pubmed_abstract><journal>Gastroenterology</journal><pubmed_title>A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.</pubmed_title><pmcid>PMC3129489</pmcid><funding_grant_id>R01 AT001576</funding_grant_id><funding_grant_id>R01 DK045334-15</funding_grant_id><funding_grant_id>R01 DK045334</funding_grant_id><funding_grant_id>P30 DK048522</funding_grant_id><funding_grant_id>R01 AT001576-09</funding_grant_id><funding_grant_id>DK45334</funding_grant_id><funding_grant_id>R01 DK051719</funding_grant_id><funding_grant_id>P30DK48522</funding_grant_id><funding_grant_id>AT1576</funding_grant_id><funding_grant_id>P30 DK048522-15</funding_grant_id><funding_grant_id>DK51719</funding_grant_id><funding_grant_id>R56 DK045334</funding_grant_id><funding_grant_id>R01 DK051719-14</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Xia M</pubmed_authors><pubmed_authors>Ko KS</pubmed_authors><pubmed_authors>Li TW</pubmed_authors><pubmed_authors>Aller MA</pubmed_authors><pubmed_authors>Peng J</pubmed_authors><pubmed_authors>Tang X</pubmed_authors></additional><is_claimable>false</is_claimable><name>A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.</name><description>&lt;h4>Background &amp; aims&lt;/h4>Cholestasis contributes to hepatocellular injury and promotes liver carcinogenesis. We created a mouse model of chronic cholestasis to study its effects on progression of cholangiocarcinoma and the oncogenes involved.&lt;h4>Methods&lt;/h4>To induce chronic cholestasis, Balb/c mice were given 2 weekly intraperitoneal injections of diethylnitrosamine (DEN); 2 weeks later, some mice also received left and median bile duct ligation (LMBDL) and, then 1 week later, were fed DEN, in corn oil, weekly by oral gavage (DLD). Liver samples were analyzed by immunohistochemical and biochemical assays; expression of Mnt and c-Myc was reduced by injection of small inhibitor RNAs.&lt;h4>Results&lt;/h4>Chronic cholestasis was induced by DLD and accelerated progression of cholangiocarcinoma, co</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Jul</publication><modification>2025-04-21T20:42:39.042Z</modification><creation>2019-03-27T03:06:40Z</creation></dates><accession>S-EPMC3129489</accession><cross_references><pubmed>21440549</pubmed><doi>10.1053/j.gastro.2011.03.044</doi></cross_references></HashMap>